Hunt for a HIV vaccine
Scientists are devising new strategies for developing an AIDS vaccine capitalising on past lessons. Shalini Gupta reports
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Nanotechnology brings new openings to stem cell R&D
Polyclone Bioservices is working on application of nanotechnology in stem cell therapy. Naveen Kulkarni, CEO and Founder,…
NEJM publishes results of two phase III studies of ocriplasmin
If approved, this could be the first pharmaceutical therapy to treat patients with vitreomacular adhesion
Statins reduce pancreatitis risk, while fibrates may increase it: Study
The study pooled data from all previously conducted large fibrate and statin trials
Granules India on the Growth Path
Granules India is one of the world's leading manufacturers of Active Pharmaceuticals Ingredients (APIs), Pharmaceutical…
Tasting new trends in health supplements market
CubeX’s comprehensive report titled ‘Tasting New Trends in the Indian Health Supplements Market’, gives a detailed understanding…
Exim Bank releases study on Indian chemical industry
Study titled ‘Indian Chemical Industry: Exploring Global Demand’, shows that Indian chemical industry has a lot of export…
‘Mylan can set a new standard in the treatment of HIV/AIDS in India’
Mylan recently started commercial operations in India with the launch of 18 ARVs, including heat stable, combination, and…
ICDR rules in favour of Glenmark wins ruling to commercialise, distribute Crofelemer
The International Centre for Dispute Resolution (ICDR) ruled in favour of Glenmark on the arbitration claim it filed on August 8,…
India, Sri Lanka to jointly fund pharma hub
Sri Lankan pharma hub to be ready in the next two years, Pharmexcil to promote exports from India